NDC 47335-625

ASPRUZYO SPRINKLE

Ranolazine

ASPRUZYO SPRINKLE is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is Ranolazine.

• Product ID: 47335-625_110acc77-c51e-465f-8d01-2c01f69af87b
• NDC: 47335-625
• Product Type: Human Prescription Drug
• Proprietary Name: ASPRUZYO SPRINKLE
• Generic Name: Ranolazine
• Dosage Form: Granule
• Route of Administration: ORAL
• Marketing Start Date: 2022-02-28
• Marketing Category: NDA /
• Application Number: NDA216018
• Labeler Name: SUN PHARMACEUTICAL INDUSTRIES, INC.
• Substance Name: RANOLAZINE
• Active Ingredient Strength: 1000 mg/1
• Pharm Classes: Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 47335-625-11

1 GRANULE in 1 PACKET (47335-625-11)

• Marketing Start Date: 2022-02-28
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "ASPRUZYO SPRINKLE" or generic name "Ranolazine"

NDC	Brand Name	Generic Name
47335-624	ASPRUZYO SPRINKLE	Ranolazine
47335-625	ASPRUZYO SPRINKLE	Ranolazine
43353-880	Ranexa	RANOLAZINE
27241-125	Ranolazine	Ranolazine
27241-126	Ranolazine	Ranolazine
31722-668	Ranolazine	Ranolazine
31722-669	Ranolazine	Ranolazine
42291-773	Ranolazine	RANOLAZINE
42291-774	Ranolazine	RANOLAZINE
42385-963	Ranolazine	Ranolazine
42385-964	Ranolazine	Ranolazine
42571-324	Ranolazine	Ranolazine
42571-325	Ranolazine	Ranolazine
43975-289	Ranolazine	Ranolazine
43975-290	Ranolazine	Ranolazine
45963-418	Ranolazine	Ranolazine
45963-419	Ranolazine	Ranolazine
48792-7893	RANOLAZINE	ranolazine
48792-7894	RANOLAZINE	ranolazine
50228-423	RANOLAZINE	RANOLAZINE
50228-424	RANOLAZINE	RANOLAZINE
50268-722	Ranolazine	Ranolazine